(Q33382309)

26 July 2017

title

Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study (English)

1 reference

26 July 2017

1 reference

1 reference

6

Alexander Knuth

1 reference

26 July 2017

7

Elke Jäger

1 reference

26 July 2017

Akin Atmaca

1

1 reference

26 July 2017

Salah-Eddin Al-Batran

2

1 reference

26 July 2017

Antje Neumann

3

1 reference

26 July 2017

Yvonne Kolassa

4

1 reference

26 July 2017

Dirk Jäger

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

6 December 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

112

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

384-388

1 reference

26 July 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Cytokine induction in humans by 41.8 degrees C whole-body hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Cytokine induction by 41.8 degrees C whole body hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Recurrent ovarian cancer: how important is it to treat to disease progression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.001

10.1016/J.YGYNO.2008.11.001

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference